随着国家食品药品监督管理局对基本药品全面实施全品种电子监管相关政策的出台,药监码的实施已从重点药品普及至基本药品,国家医药卫生体制改革的进一步深化和国内药品市场的深度规范已箭在弦上。对所有制药企业来说,这是一场机遇与危机并存的严峻挑战。 With the State Food and Drug Administration’s full implementation of the full range of essential medicines related to electronic regulatory policies, the implementation of the drug code has shifted from key drugs to essential medicines, the further deepening of the national medical and health system reform and the depth of the domestic pharmaceutical market The specification is on the verge of it. For all pharmaceutical companies, this is a serious challenge both in terms of opportunities and crises.